1. Home
  2. Labeler Index
  3. Northwind Pharmaceuticals
  4. NDC Product Code: 51655-500 Pantoprazole Sodium Delayed Release

NDC 51655-500 Pantoprazole Sodium Delayed Release

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 51655-500?
  5. Pantoprazole Sodium Delayed Release Uses
  6. Active Ingredients UNII Codes
  7. NDC to RxNorm Crosswalk
  8. Patient Education

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
51655-500
Proprietary Name:
Pantoprazole Sodium Delayed Release
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Northwind Pharmaceuticals
Labeler Code:
51655
Product Label ID:
bf31d3db-ed75-4513-a3a9-a163b5a5dceb
Start Marketing Date: [9]
03-21-2014
Listing Expiration Date: [11]
12-31-2018
Exclude Flag: [12]
I
Code Navigator:

Product Characteristics

Color(s):
YELLOW (C48330)
Shape:
OVAL (C48345)
Size(s):
11 MM
Imprint(s):
M;P9
Score:
1

Code Structure Chart

Product Details

What is NDC 51655-500?

The NDC code 51655-500 is assigned by the FDA to the product Pantoprazole Sodium Delayed Release which is product labeled by Northwind Pharmaceuticals. The product's dosage form is . The product is distributed in a single package with assigned NDC code 51655-500-52 30 tablet, delayed release in 1 bottle, dispensing . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Pantoprazole Sodium Delayed Release?

Pantoprazole is a proton pump inhibitor indicated for the following:•Short-term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD). •Maintenance of Healing of Erosive Esophagitis. •Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome.

Which are Pantoprazole Sodium Delayed Release UNII Codes?

The UNII codes for the active ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Pantoprazole Sodium Delayed Release?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 314200 - pantoprazole sodium 40 MG Delayed Release Oral Tablet
  • RxCUI: 314200 - pantoprazole 40 MG Delayed Release Oral Tablet
  • RxCUI: 314200 - pantoprazole 40 MG (as pantoprazole sodium sesquihydrate 45.1 MG) Delayed Release Oral Tablet

* Please review the disclaimer below.

Patient Education

Pantoprazole


Pantoprazole is used to treat damage from gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and possible injury of the esophagus (the tube between the throat and stomach) in adults and children 5 years of age and older. Pantoprazole is used to allow the esophagus to heal and prevent further damage to the esophagus in adults with GERD. It is also used to treat conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome in adults. Pantoprazole is in a class of medications called proton-pump inhibitors. It works by decreasing the amount of acid made in the stomach.
[Learn More]


* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".